Back

Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography

25 August 2023 (17:15 - 17:45)
Organised by: Logo
Congress Presentation Part of: Innovations in public health and health economics (1) Public Health ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Jaehoon Chung

Dongguk University International Hospital, Goyang (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.
Professor A. Goette (Paderborn, DE)
Abstract Slides Video
Presentation thumbnail
Quantity and quality of shared decision making incorporation across major international cardiology guidelines
Doctor B. MacDonald (Vancouver, CA)
Abstract Slides Video
Presentation thumbnail
Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries
Doctor M. Walli-Attaei (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study
Mr A. Holt (Copenhagen, DK) Miss J. Liang (Auckland, NZ)
Abstract Slides Video

Access the full session

Session thumbnail
Innovations in public health and health economics (1)

The Event

Event poster

ESC Congress 2023

25 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Socioeconomic status and myocardial infarction: a key predictor of risk profile and long-term prognosis
thumbnail
Congress Presentation
Socioeconomic status and cardiovascular mortality in over 170,000 cancer survivors: a population-based cohort study
thumbnail
Congress Presentation
Impact of growing up in a low-income household on midlife coronary atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources